Skip to main content

Table 3 Multivariate analysis of clinical outcomes

From: BRAF mutation correlates with worse local–regional control following radiation therapy in patients with stage III melanoma

Variable Local–Regional (LN) Control P DMFS P RFS P OS P
BRAF status
 Negative 0.02 0.94 0.46 0.94
 Positive 4.49 (1.3–15.5)   0.98 (0.55–1.7)   1.23 (0.71–2.1)   1.02 (0.55–1.9)  
# of LNs positive
 < 4 0.03 0.07 0.04 0.01
 ≥ 4 2.79 (1.1–6.9)   1.80 (0.95–3.4)   1.87 (1.0–3.4)   2.26 (1.18–4.3)  
Adjuvant systemic Tx
 No    0.09 0.04   
 Yes    0.62 (0.35–1.1)   0.57 (0.3–0.96)